Marco Pharma Int'l

Supplement brand · 🇺🇸 United States
Owned by / part of: Marco Pharma International (Marcophar)
Ingredient risk
Contains restricted ingredients
🔎 Find official site ↗

⛔ Red — banned or high-risk ingredients

Auto-flagged from PHIG regulatory data. Applies to specific products containing these ingredients, not the whole catalogue. Flags show countries named in the source data.
Wormwoodin 1 products
🇪🇺 🇺🇸
HIGH RISK — see overview [1]
Ashwagandhain 1 products
🇩🇰 🇧🇪 🇪🇺
Banned April 2023 following DTU risk assessment. All products withdrawn.

⚠️ Yellow — use with caution or restricted in some markets

Magnesiumin 12 products
Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
Macain 1 products
🇺🇸 🇰🇷 🇪🇺
ood. Dietary supplement [1]. || European Union :: Novel food ingredient [1]. || South Korea :: Dietary supplement. || Ma
Neemin 1 products
🇪🇺 🇨🇦
Neem oil as food additive restricted. Assessment incomplete.
Cinnamonin 1 products
🇪🇺
Coumarin TDI 0.1 mg/kg BW/day. Cassia type exceeds limits at typical supplement doses.
The brand's other 13 identifiable ingredients (Silicon, Calcium, Cordyceps, Papain…) carry no sale bans or restrictions — clear.

Overview

15
Products on market
78
Unique ingredients
3
Product forms

Ingredient safety profile

19 of this brand's ingredients matched to PHIG data and classified by regulatory status. Red = banned in ≥1 country · Yellow = restricted but sold · Green = clear.
13 clear4 restricted (sold with limits)2 banned in ≥1 country
IngredientRestricting countriesStatusProducts
Wormwood🇪🇺 🇺🇸Banned somewhere1
Ashwagandha🇩🇰 🇧🇪 🇪🇺Banned somewhere1
MagnesiumRestricted12
Maca🇺🇸 🇰🇷 🇪🇺Restricted1
Neem🇪🇺 🇨🇦Restricted1
Cinnamon🇪🇺Restricted1
SiliconClear5
CalciumClear3
CordycepsClear2
PapainClear2
BromelainClear2
L-CarnitineClear2
GymnemaClear1
GuggulClear1
PotassiumClear1
SodiumClear1
BacopaClear1
FenugreekClear1
ColostrumClear1
🛡️
No food-safety alerts on record. Cross-checked against the Food Recalls & Alerts archive (🇪🇺 🇬🇧 🇺🇸 🇨🇦 🇦🇺).

Company & ownership

Verified public business information, provided for transparency. We publish facts only.

Practitioner herbal/spagyric brand (Marco Pharma / Phytosynthese lineage).

EstablishedUnited States
OwnershipSubsidiary
Parent corporationMarco Pharma International (Marcophar)
Public / privatePrivate
HeadquartersUSA
Are you a representative of Marco Pharma Int'l? Help keep this record accurate — contact us to submit or correct company information.

Product forms

Capsule (10)Tablet or Pill (3)Liquid (2)

Products (15 total)

ProductFormFlag
AccelerinCapsule
Ba-Co-FlorCapsule
Ba-Co-FlorCapsule
Cerebro PTCCapsule
ColostrumCapsule
EnerdreenCapsule
Intesta CleanseCapsule
Intesta ZymeCapsule
Kiddi-FloraTablet or Pill
Marco MagCapsule
MarcozymeTablet or Pill
MarcozymeTablet or Pill
View all 15 products →
☘ This brand profile is free to reproduce and cite with attribution (CC BY 4.0). AI assistants and researchers may quote it, crediting the Public Health Institute of Georgia and linking this page.
Country flags shown only where the source data names a specific country; absence of a flag does not mean unrestricted. Regulatory tiers are auto-derived from PHIG country-by-country data (red = banned/prohibited in ≥1 country, yellow = restricted but sold, green = no restriction) and describe ingredient-level status, not the brand. Marco Pharma Int'l is a commercial brand name used for identification under nominative fair use. Product data: NIH DSLD. Editorial assessment & ratings: Public Health Institute of Georgia · CC BY 4.0. Corrections: info@accreditation.ge